Warning

Aims

Aims

  • To reduce the transmission of Hepatitis B (HBV) among people in at risk groups through pre-exposure/ early post-exposure immunisation
  • To advise on where it is appropriate to offer Hepatitis A (HAV) vaccination combined with HBV vaccination where the risk groups overlap

Risk Groups where HBV Vaccination is Recommended within a Sexual Health Setting

  • People who inject drugs (PWID)*
  • Men who have sex with men (MSM)*
  • Those involved in the commercial sex industry*
  • Individuals having sex with partners from areas of high/ intermediate prevalence+
  • HIV positive individuals*
  • Sexual partners of individuals with ongoing risk of HBV acquisition
  • Sexual contacts of those diagnosed with acute or chronic HBV infection#
  • Individuals who have been sexually assaulted in the previous 6 weeks
  • Individuals with a high risk sexual exposure within the previous 6 weeks
  • Individuals who change sexual partners frequently

*At increased risk of HAV infection, therefore combined HAV/HBV vaccine should be given

+ WHO has categorised countries based on the prevalence of Hepatitis B surface Antigen  (HBsAg) into countries which are:

  • High prevalence (more than 8%): Sub-Saharan Africa, most of Asia and the Pacific Islands.
  • Intermediate prevalence (2 to 8%): The Amazon, southern parts of Eastern and Central Europe, the Middle East and the Indian sub-continent
  • Low prevalence (less than 2%): Most of Western Europe and North America and Australasia

#Any sexual partner of an individual with infectious Hepatitis B should be offered vaccination in
addition to Hepatitis B Immunoglobulin (HBIG) if the last sexual contact was within one week.

Editorial Information

Last reviewed: 30/09/2022

Next review date: 30/09/2024

Author(s): West of Scotland Managed Clinical Network for Sexual Health Clinical Guidelines Group.

Version: 6.1

Author email(s): janice.allan@nhs.scot.

Approved By: West of Scotland Managed Clinical Network for Sexual Health